IPS
RPRX icon

Investors Portfolio Services’s Royalty Pharma RPRX Stock Holding History

Investors Portfolio Services’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$336 Hold
6
– – ﹤0.01% 609
2026
Q1 		$316 Buy
+6
New +$263 ﹤0.01% 629

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Investors Portfolio Services's RPRX Position: Q2 2026 in Review

Investors Portfolio Services held its Royalty Pharma (RPRX) position steady in Q2 2026 at 6 shares worth $336. The position accounts for ﹤0.01% of the portfolio, ranked #609.

Investors Portfolio Services first reported a position in RPRX in Q1 2026 and has held it in 2 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Investors Portfolio Services held 6 shares of Royalty Pharma worth $336 as of Q2 2026.
  • Investors Portfolio Services left its Royalty Pharma share count unchanged in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of Investors Portfolio Services's portfolio in Q2 2026, its #609 holding.
  • Investors Portfolio Services first reported a position in Royalty Pharma in Q1 2026 and has held it in 2 quarters since.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Investors Portfolio Services's 13F filing for Q2 2026, filed 14 Aug 2026.